Article

Dr. Lindstrom joins Refractec board of directors

Irvine, CA-Ophthalmic device manufacturer Refractec Inc. announced the appointment of Richard L. Lindstrom, MD, of Minnesota Eye Consultants, to its six-member board of directors.

Dr. Lindstrom holds more than 30 patents for the design of several ophthalmic devices and instruments that are used in clinical practices worldwide. He currently serves as medical director of TLC Vision and Midwest Surgical Services, associate director of the Minnesota Lions Eye Bank, and is a member of the boards of directors of TLC Vision, Occulogix, eyeonics, and the Minnesota Medical Foundation.

"We consider Dr. Lindstrom's expertise, particularly in vision-correction technologies and the treatment of presbyopia, a tremendous asset, and we are fortunate to have his counsel in the continued growth of our company and its core technologies," said Thomas G. Frinzi, Refractec's chief executive officer.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.